To determine whether the CD34− and CD34+ sphere-forming cells could initiate tumors in vivo, we inoculated Rag1 mice with 100 spheres from either CD34− or CD34+ tumor cells via the retro-orbital sinus, delivering them directly to the lungs. The gene discussed is CD34; the disease is neoplasm.